New Research In
Physical Sciences
Social Sciences
Featured Portals
Articles by Topic
Biological Sciences
Featured Portals
Articles by Topic
- Agricultural Sciences
- Anthropology
- Applied Biological Sciences
- Biochemistry
- Biophysics and Computational Biology
- Cell Biology
- Developmental Biology
- Ecology
- Environmental Sciences
- Evolution
- Genetics
- Immunology and Inflammation
- Medical Sciences
- Microbiology
- Neuroscience
- Pharmacology
- Physiology
- Plant Biology
- Population Biology
- Psychological and Cognitive Sciences
- Sustainability Science
- Systems Biology
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
-
Edited by Lewis T. Williams, Five Prime Therapeutics, Emeryville, CA, and approved December 18, 2007 (received for review August 31, 2007)

Abstract
Antimicrobial peptides (AMPs) and their mimics are emerging as promising antibiotic agents. We present a library of “ampetoids” (antimicrobial peptoid oligomers) with helical structures and biomimetic sequences, several members of which have low-micromolar antimicrobial activities, similar to cationic AMPs like pexiganan. Broad-spectrum activity against six clinically relevant BSL2 pathogens is also shown. This comprehensive structure–activity relationship study, including circular dichroism spectroscopy, minimum inhibitory concentration assays, hemolysis and mammalian cell toxicity studies, and specular x-ray reflectivity measurements shows that the in vitro activities of ampetoids are strikingly similar to those of AMPs themselves, suggesting a strong mechanistic analogy. The ampetoids' antibacterial activity, coupled with their low cytotoxicity against mammalian cells, make them a promising class of antimicrobials for biomedical applications. Peptoids are biostable, with a protease-resistant N-substituted glycine backbone, and their sequences are highly tunable, because an extensive diversity of side chains can be incorporated via facile solid-phase synthesis. Our findings add to the growing evidence that nonnatural foldamers will emerge as an important class of therapeutics.
Footnotes
- ‖To whom correspondence should be sent at the present address: Department of Bioengineering, Stanford University, W300B James H. Clark Center, 318 Campus Drive, Stanford, CA 94305. E-mail: aebarron{at}stanford.edu
-
Author contributions: N.P.C. and J.A.P contributed equally to this work; N.P.C., J.A.P., D.G., R.N.Z., and A.E.B. designed research; N.P.C., J.A.P., A.M.C., M.T.D., and D.G. performed research; D.G. and R.N.Z. contributed new reagents/analytic tools; N.P.C., J.A.P., A.M.C., M.T.D., A.I., and D.G. analyzed data; and N.P.C., J.A.P., A.M.C., M.T.D., and A.E.B. wrote the paper.
-
↵ †Present address: Wyeth Research, 401 North Middletown Road, Pearl River, NY 10965.
-
The authors declare no conflict of interest.
-
This article is a PNAS Direct Submission.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0708254105/DC1.
- © 2008 by The National Academy of Sciences of the USA